-
March 2026
Q1 2026 Index Review Complete
The quarterly review of LSCIBP and LSCIBC eligibility criteria has been completed. No interim changes to either index.
-
December 2025
Semi-Annual Reconstitution — December 2025
LSCIBP and LSCIBC have been reconstituted effective market open December 22, 2025. Updated constituent lists reflect current FDA approval status and clinical trial classifications.
-
June 2025
Semi-Annual Reconstitution — June 2025
LSCIBP and LSCIBC have been reconstituted effective market open June 23, 2025. Component counts: LSCIBP 63, LSCIBC 126.
-
December 2024
Semi-Annual Reconstitution — December 2024
Both indexes reconstituted effective December 23, 2024. LSCIBP: 61 components. LSCIBC: 119 components.
-
June 2024
Semi-Annual Reconstitution — June 2024
Semi-annual reconstitution completed. LSCIBP: 59 components. LSCIBC: 115 components.
-
December 2023
Semi-Annual Reconstitution — December 2023
Both indexes reconstituted effective December 18, 2023.